Concerns Raised over Bextra Scientists say the arthritis drug Bextra may pose increased risk of cardiovascular troubles. Bextra is related to Vioxx, which was pulled off the market in September for the same reason. Now, doctors worry that all related drugs could cause similar problems. Hear NPR's Richard Knox.
NPR logo

Scientists Raise Concerns about Arthritis Drug Bextra

  • Download
  • <iframe src="https://www.npr.org/player/embed/4164569/4164570" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Scientists Raise Concerns about Arthritis Drug Bextra

Scientists Raise Concerns about Arthritis Drug Bextra

Scientists Raise Concerns about Arthritis Drug Bextra

  • Download
  • <iframe src="https://www.npr.org/player/embed/4164569/4164570" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Scientists say the arthritis drug Bextra may pose increased risk of cardiovascular troubles. Bextra is related to Vioxx, which was pulled off the market in September for the same reason. Now, doctors worry that all related drugs could cause similar problems. Hear NPR's Richard Knox.